Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).

J.S.H. Vles; F.J.M. Feron; J.G.M. Hendriksen; J. Jolles; M.J.P.G. van Kroonenburgh; W.E.J. Weber

doi:10.1055/s-2003-39602

Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).

J.S.H. Vles^*, F.J.M. Feron, J.G.M. Hendriksen, J. Jolles, M.J.P.G. van Kroonenburgh, W.E.J. Weber

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

2262 Downloads (Pure)

Abstract

Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).

Vles JS, Feron FJ, Hendriksen JG, Jolles J, van Kroonenburgh MJ, Weber WE.

Department of Child Neurology, University Hospital Maastricht, Maastricht, The Netherlands. jvle@sneu.azm.nl

Adults suffering from Attention Deficit Hyperactivity Disorder (ADHD) are known to have disturbed central dopaminergic transmission. With Single Photon Emission Computed Tomography (SPECT) we studied brain dopamine transporter and receptor activity in six boys with ADHD. Three months after initiation of treatment with methylphenidate we found a down-regulation of the post-synaptic dopamine receptor with a maximum of 20 % and a down-regulation of the dopamine transporter with a maximum of 74.7 % in the striatal system. This corresponded to a positive clinical response evaluated by neuropsychological questionnaires and tests. We suggest that dopamine transporter imaging by SPECT might be used to monitor psychostimulant treatment in children suffering from ADHD

Original language	English
Pages (from-to)	77-80
Number of pages	3
Journal	Neuropediatrics
Volume	34
Issue number	2
DOIs	https://doi.org/10.1055/s-2003-39602
Publication status	Published - 1 Jan 2003

Access to Document

10.1055/s-2003-39602

Full TextFinal published version, 58.4 KB

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12776228&dopt=Abstract

Cite this

@article{47321910f42b4852b719aaf57f1163c4,

title = "Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).",

abstract = "Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).Vles JS, Feron FJ, Hendriksen JG, Jolles J, van Kroonenburgh MJ, Weber WE.Department of Child Neurology, University Hospital Maastricht, Maastricht, The Netherlands. jvle@sneu.azm.nlAdults suffering from Attention Deficit Hyperactivity Disorder (ADHD) are known to have disturbed central dopaminergic transmission. With Single Photon Emission Computed Tomography (SPECT) we studied brain dopamine transporter and receptor activity in six boys with ADHD. Three months after initiation of treatment with methylphenidate we found a down-regulation of the post-synaptic dopamine receptor with a maximum of 20 % and a down-regulation of the dopamine transporter with a maximum of 74.7 % in the striatal system. This corresponded to a positive clinical response evaluated by neuropsychological questionnaires and tests. We suggest that dopamine transporter imaging by SPECT might be used to monitor psychostimulant treatment in children suffering from ADHD",

author = "J.S.H. Vles and F.J.M. Feron and J.G.M. Hendriksen and J. Jolles and {van Kroonenburgh}, M.J.P.G. and W.E.J. Weber",

year = "2003",

month = jan,

day = "1",

doi = "10.1055/s-2003-39602",

language = "English",

volume = "34",

pages = "77--80",

journal = "Neuropediatrics",

issn = "0174-304X",

publisher = "Georg Thieme Verlag",

number = "2",

}

TY - JOUR

T1 - Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).

AU - Vles, J.S.H.

AU - Feron, F.J.M.

AU - Hendriksen, J.G.M.

AU - Jolles, J.

AU - van Kroonenburgh, M.J.P.G.

AU - Weber, W.E.J.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).Vles JS, Feron FJ, Hendriksen JG, Jolles J, van Kroonenburgh MJ, Weber WE.Department of Child Neurology, University Hospital Maastricht, Maastricht, The Netherlands. jvle@sneu.azm.nlAdults suffering from Attention Deficit Hyperactivity Disorder (ADHD) are known to have disturbed central dopaminergic transmission. With Single Photon Emission Computed Tomography (SPECT) we studied brain dopamine transporter and receptor activity in six boys with ADHD. Three months after initiation of treatment with methylphenidate we found a down-regulation of the post-synaptic dopamine receptor with a maximum of 20 % and a down-regulation of the dopamine transporter with a maximum of 74.7 % in the striatal system. This corresponded to a positive clinical response evaluated by neuropsychological questionnaires and tests. We suggest that dopamine transporter imaging by SPECT might be used to monitor psychostimulant treatment in children suffering from ADHD

AB - Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).Vles JS, Feron FJ, Hendriksen JG, Jolles J, van Kroonenburgh MJ, Weber WE.Department of Child Neurology, University Hospital Maastricht, Maastricht, The Netherlands. jvle@sneu.azm.nlAdults suffering from Attention Deficit Hyperactivity Disorder (ADHD) are known to have disturbed central dopaminergic transmission. With Single Photon Emission Computed Tomography (SPECT) we studied brain dopamine transporter and receptor activity in six boys with ADHD. Three months after initiation of treatment with methylphenidate we found a down-regulation of the post-synaptic dopamine receptor with a maximum of 20 % and a down-regulation of the dopamine transporter with a maximum of 74.7 % in the striatal system. This corresponded to a positive clinical response evaluated by neuropsychological questionnaires and tests. We suggest that dopamine transporter imaging by SPECT might be used to monitor psychostimulant treatment in children suffering from ADHD

U2 - 10.1055/s-2003-39602

DO - 10.1055/s-2003-39602

M3 - Article

SN - 0174-304X

VL - 34

SP - 77

EP - 80

JO - Neuropediatrics

JF - Neuropediatrics

IS - 2

ER -